Aranda Pharma Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 4

Aranda Pharma General Information

Description

Developer of drugs intended to combat prostate cancer and neurodegenerative diseases. The company's drugs are made of small molecules and androgen receptor antagonists that are non-toxic, enabling patients to avail treatment at a lower cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Microkatu 1
  • Post Office Box 1199
  • 70150 Kuopio
  • Finland
+358 044 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aranda Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Oct-2021 Completed Clinical Trials - General
2. Seed Round 04-Nov-2015 Completed Startup
1. Angel (individual) Completed Startup
To view Aranda Pharma’s complete valuation and funding history, request access »

Aranda Pharma Patents

Aranda Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2715877-T3 Use of fused benzo [b] thiazine derivatives as cytoprotectors Active 31-May-2013 0000000000
US-20160106754-A1 Use of condensed benzo[b]thiazine derivatives as cytoprotectants Granted 31-May-2013 0000000000
US-9827249-B2 Use of condensed benzo[b]thiazine derivatives as cytoprotectants Active 31-May-2013 0000000000
EP-3004118-B1 Use of condensed benzo[b]thiazine derivatives as cytoprotectants Active 31-May-2013 0000000000
EP-3004118-A1 Use of condensed benzo[b]thiazine derivatives as cytoprotectants Granted 31-May-2013 A61K31/542
To view Aranda Pharma’s complete patent history, request access »

Aranda Pharma Executive Team (5)

Name Title Board Seat Contact Info
Anu Muona Ph.D Chief Executive Officer & Co-Founder
Gundars Goldsteins Ph.D Co-Founder & Scientific Collaborator
Milla Koistinaho Ph.D Co-Founder & Board Member
Heikki Eronen Manager, Company Administration and Finance
Jari Koistinaho Ph.D Co-Founder & Scientific Collaborator
To view Aranda Pharma’s complete executive team members history, request access »

Aranda Pharma Board Members (5)

Name Representing Role Since
Aki Prihti Self Board Member 000 0000
Jyrki Mattila Ph.D Self Chairman 000 0000
Milla Koistinaho Ph.D Aranda Pharma Co-Founder & Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Aranda Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aranda Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tesi Fund of Funds Minority 000 0000 000000 0
Finnvera Venture Capital Minority 000 0000 000000 0
Innovestor Venture Capital Minority 000 0000 000000 0
Tarrex Biopharma Corporation Minority 000 0000 000000 0
To view Aranda Pharma’s complete investors history, request access »